172 related articles for article (PubMed ID: 32375331)
1. Breakthrough Pain in Patients with Lung Cancer. A Secondary Analysis of IOPS MS Study.
Mercadante S; Masedu F; Valenti M; Aielli F
J Clin Med; 2020 May; 9(5):. PubMed ID: 32375331
[TBL] [Abstract][Full Text] [Related]
2. Breakthrough pain in patients with multiple myeloma: a secondary analysis of IOPS MS study.
Mercadante S; Caraceni A; Cuomo A; Mammucari M; Marchetti P; Mediati RD; Natoli S; Tonini G
Eur Rev Med Pharmacol Sci; 2023 Feb; 27(3):1134-1139. PubMed ID: 36808361
[TBL] [Abstract][Full Text] [Related]
3. Breakthrough pain in patients with head & neck cancer. A secondary analysis of IOPS MS study.
Mercadante S; Masedu F; Valenti M; Aielli F
Oral Oncol; 2019 Aug; 95():87-90. PubMed ID: 31345399
[TBL] [Abstract][Full Text] [Related]
4. Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain.
Mercadante S; Caraceni A; Masedu F; Scipioni T; Aielli F
Oncologist; 2020 Feb; 25(2):156-160. PubMed ID: 31862860
[TBL] [Abstract][Full Text] [Related]
5. A Longitudinal Study of Breakthrough Cancer Pain: An Extension of IOPS-MS Study.
Mercadante S; Caraceni A; Cuomo A; Mammucari M; Marchetti P; Mediati RD; Natoli S; Tonini G
J Clin Med; 2021 May; 10(11):. PubMed ID: 34073907
[TBL] [Abstract][Full Text] [Related]
6. The Prevalence and Characteristics of Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain.
Mercadante S; Maltoni M; Russo D; Adile C; Ferrera P; Rossi R; Rosati M; Casuccio A
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33801478
[TBL] [Abstract][Full Text] [Related]
7. Breakthrough Cancer Pain in Patients With Abdominal Visceral Cancer Pain.
Mercadante S; Adile C; Masedu F; Valenti M; Aielli F
J Pain Symptom Manage; 2019 May; 57(5):966-970. PubMed ID: 30822530
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing the use of opioids for breakthrough cancer pain: A secondary analysis of the IOPS-MS study.
Mercadante S; Adile C; Masedu F; Marchetti P; Costanzi A; Aielli F
Eur J Pain; 2019 Apr; 23(4):719-726. PubMed ID: 30421474
[TBL] [Abstract][Full Text] [Related]
9. Multidimensional Statistical Technique for Interpreting the Spontaneous Breakthrough Cancer Pain Phenomenon. A Secondary Analysis from the IOPS-MS Study.
Cascella M; Crispo A; Esposito G; Forte CA; Coluccia S; Porciello G; Amore A; Bimonte S; Mercadante S; Caraceni A; Mammucari M; Marchetti P; Mediati RD; Natoli S; Tonini G; Cuomo A
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439173
[TBL] [Abstract][Full Text] [Related]
10. Dosing fentanyl buccal tablet for breakthrough cancer pain: dose titration versus proportional doses.
Mercadante S; Gatti A; Porzio G; Lo Presti C; Aielli F; Adile C; Casuccio A
Curr Med Res Opin; 2012 Jun; 28(6):963-8. PubMed ID: 22480130
[TBL] [Abstract][Full Text] [Related]
11. Breakthrough Cancer Pain Clinical Features and Differential Opioids Response: A Machine Learning Approach in Patients With Cancer From the IOPS-MS Study.
Pantano F; Manca P; Armento G; Zeppola T; Onorato A; Iuliani M; Simonetti S; Vincenzi B; Santini D; Mercadante S; Marchetti P; Cuomo A; Caraceni A; Mediati RD; Vellucci R; Mammucari M; Natoli S; Lazzari M; Dauri M; Adile C; Airoldi M; Azzarello G; Blasi L; Chiurazzi B; Degiovanni D; Fusco F; Guardamagna V; Liguori S; Palermo L; Mameli S; Masedu F; Mazzei T; Melotti RM; Menardo V; Miotti D; Moroso S; Pascoletti G; De Santis S; Orsetti R; Papa A; Ricci S; Scelzi E; Sofia M; Aielli F; Valle A; Tonini G
JCO Precis Oncol; 2020; 4():. PubMed ID: 33283139
[TBL] [Abstract][Full Text] [Related]
12. Patients' Satisfaction with Breakthrough Cancer Pain Therapy: A Secondary Analysis of IOPS-MS Study.
Mazzotta M; Filetti M; Piras M; Mercadante S; Marchetti P; Giusti R
Cancer Manag Res; 2022; 14():1237-1245. PubMed ID: 35356594
[TBL] [Abstract][Full Text] [Related]
13. Meaningful cut-off pain intensity for breakthrough pain changes in advanced cancer patients.
Mercadante S; Adile C; Torta R; Varetto A; Fulfaro F; Giarratano A; Casuccio A
Curr Med Res Opin; 2013 Jan; 29(1):93-7. PubMed ID: 23198976
[TBL] [Abstract][Full Text] [Related]
14. Fentanyl buccal tablets for breakthrough pain in highly tolerant cancer patients: preliminary data on the proportionality between breakthrough pain dose and background dose.
Mercadante S; Ferrera P; Adile C; Casuccio A
J Pain Symptom Manage; 2011 Sep; 42(3):464-9. PubMed ID: 21477977
[TBL] [Abstract][Full Text] [Related]
15. Impact of breakthrough pain on community-dwelling cancer patients: results from the National Breakthrough Pain Study.
Katz NP; Gajria KL; Shillington AC; Stephenson JJ; Harshaw Q
Postgrad Med; 2017 Jan; 129(1):32-39. PubMed ID: 27846789
[TBL] [Abstract][Full Text] [Related]
16. Breakthrough Cancer Pain Influences General Activities and Pain Management: A Comparison of Patients with and without Breakthrough Cancer Pain.
Tagami K; Okizaki A; Miura T; Watanabe YS; Matsumoto Y; Morita T; Fujimori M; Kinoshita H
J Palliat Med; 2018 Nov; 21(11):1636-1640. PubMed ID: 29975582
[TBL] [Abstract][Full Text] [Related]
17. Relationship between background cancer pain, breakthrough pain, and analgesic treatment: a preliminary study for a better interpretation of epidemiological and clinical studies.
Mercadante S; Valle A; Porzio G; Aielli F; Adile C; Ficorella C; Raineri M; Giarratano A; Casuccio A
Curr Med Res Opin; 2013 Jun; 29(6):667-71. PubMed ID: 23551065
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of sublingual fentanyl vs. oral morphine for cancer-related breakthrough pain.
Velázquez Rivera I; Muñoz Garrido JC; García Velasco P; España Ximénez de Enciso I; Velázquez Clavarana L
Adv Ther; 2014 Jan; 31(1):107-17. PubMed ID: 24385406
[TBL] [Abstract][Full Text] [Related]
19. Fentanyl buccal tablet for breakthrough cancer pain in clinical practice: results of the non-interventional prospective study ErkentNIS.
Masel EK; Landthaler R; Gneist M; Watzke HH
Support Care Cancer; 2018 Feb; 26(2):491-497. PubMed ID: 28849261
[TBL] [Abstract][Full Text] [Related]
20. Interference with daily functioning by breakthrough pain in patients with cancer.
Kang JH; Koh SJ; Oh SY; Kim RB; Shin SH; Lee YG; Kim BS; Ryoo HM; Yoon SY; Jang JS; Oh HS; Choi YJ; Lee MH; Lee KH
Support Care Cancer; 2020 Nov; 28(11):5177-5183. PubMed ID: 32056013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
